OPT 1.27% 78.0¢ opthea limited

Thanks for the post Sol, sets me up for a relaxing weekend....

  1. 2,940 Posts.
    lightbulb Created with Sketch. 189
    Thanks for the post Sol, sets me up for a relaxing weekend. Found this little bit on Shane Storey that adds credibility to his credentials giving advice in the biotech space.

    Shane Storey joined Wilson HTM Investment Group in late 2007 as a senior research analyst, covering healthcare, pharmaceuticals, medical devices and biotechnology. He is now head of research. Storey has nearly 20 years experience in these fields, as a molecular biologist, process engineer, consultant, venture capital financier and senior executive. Before joining Wilson HTM, Storey managed investments for one of Australia's first venture capital funds to specialize to emerging Australian biotechnology companies. The fund outperformed the top quartile returns from U.S. venture funds of an equivalent vintage. Storey holds bachelor's degrees in science and chemical engineering from the University of Queensland, a Ph.D. in biochemical engineering from University College London, and a master's degree in business administration from the Macquarie Graduate School of Management.

    Have added in the last few days shares and options so staying with a buy!
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.